Very proud to have played a small part in this important study! Congratulations to @arricoomarasamy and his fantastic team!
I’m very encouraged by the E-MOTIVE Trial results released today at #IMNHC2023 to treat postpartum hemorrhage, the #1 cause of maternal mortality. This new approach led by @unibirmingham and @WHO could drastically improve women’s chances of surviving childbirth globally. b-gat.es/3BclMsw
Anne Ammerdorffer retweeted
🚨@EmotiveTrial results published in @NEJM today & presented at #IMNHC2023, Cape Town! 🇿🇦bit.ly/42AGEFf 60% relative reduction in primary outcome: severe PPH, laparotomy for bleeding or maternal death from bleeding @gatesfoundation @WHO @HRPresearch @unibirmingham
In a large, cluster-randomized trial involving patients with PPH after vaginal delivery, a multicomponent intervention lowered the risk of severe PPH, laparotomy for bleeding, or maternal death from bleeding. Full results of the E-MOTIVE trial: nej.md/3O6GTEn
#IMNHC2023
Anne Ammerdorffer retweeted
35% of oxytocin-TXA combinations led to reduction in oxytocin concentration. Avoid combining! @AnneAmmer @ConceptFNDN @gulmezoglum @alignmnh #IMNHC2023
Anne Ammerdorffer retweeted
In partnership with Concept Foundation
Some women will face medical complications during and after pregnancy, so why are there only 2 drugs developed for pregnant women?
This isn't a # ad. #pregnant #pregnancy #Medical #healthcare #WomensHealth
Anne Ammerdorffer retweeted
Together with academic partners, we evaluate the effectiveness of routine antibiotic prophylaxis to women undergoing uterine evacuation procedures to treat miscarriage.
Read the protocol:
doi.org//10.1002/14651858.CD…
#cochrane #review #protocol #miscarriage #prophylaxis #antibiotics
Anne Ammerdorffer retweeted
📢Our ED Metin Gülmezoglu (@gulmezoglum) spoke to @thetimes about @ConceptFNDN’s #PSA on how there are #ONLYTWODRUGSEVER to be produced for #pregnancy-specific conditions.
SPOILER: We want to #endtheexclusion of pregnant women in research!
More below⬇️bit.ly/3AFr2Ux
Anne Ammerdorffer retweeted
🚨There are #ONLYTWODRUGSEVER to be produced for pregnancy specific conditions.
#Pregnant women must be given access to specific #medicines to ensure they have a safe and healthy pregnancy.
Join the conversation, be the change!
Watch here: bit.ly/3Ei1nlH
Anne Ammerdorffer retweeted
🚨 #Pregnant women must be included in research trials to ensure new #medicines are developed. 🚨
#ONLYTWODRUGSEVER have been produced for pregnancy-specific conditions. Let's change that!
Featuring Doctor @nelson_piercy, watch our #PSA below ⬇️ bit.ly/3A9CaJ2
Anne Ammerdorffer retweeted
🚨 #PSA ALERT! 🚨
#Pregnancy is supposed to be a time of joy, but for many expecting mothers it can also be a complex journey with major health risks.
So why have #ONLYTWODRUGSEVER been produced for pregnancy specific conditions? 🤔
Find out more ⬇️ bit.ly/3A9CaJ2
Anne Ammerdorffer retweeted
People go to space. 🚀
Advanced scientific discoveries.🔬
Computers in our pockets.📱
Yet, why are there only #ONLYTWODRUGSEVER to tackle #pregnancy specific conditions? 🤔
Join us as we call for pregnant #women to be included in research trials: bit.ly/3A9CaJ2
Anne Ammerdorffer retweeted
Protocol @cochranecollab: #Prophylactic #antibiotics for uterine evacuation procedures to treat #miscarriage cochranelibrary.com/cdsr/doi… Sheikh Irfan Ahmed @AnneAmmer @arricoomarasamy @DavidLissauer @amiewil et al








